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Abstract: Contact heat evoked potentials (CHEPs) have become an acknowledged research tool in the
assessment of the integrity of the nociceptive system and gained importance in the diagnostic work-up
of patients with suspected small fiber neuropathy. For the latter, normative values for CHEP amplitude
and latency are indispensable for a clinically meaningful interpretation of the results gathered in patients.
To this end, CHEPs were recorded in 100 healthy subjects over a wide age range (20-80 years) and from
three different dermatomes of the lower extremities (L2, L5, and S2). A normal baseline (35-52 °C) and
increased baseline stimulation (42-52 °C) were applied. Statistical analysis revealed significant effects
of stimulation site, stimulation intensity, and sex on CHEP parameters (N2 latency, N2P2 amplitude,
and NRS). Significant positive correlations of body height with N2 latency, and pain ratings with N2P2
amplitudes were observed. This is the first time that normative values have been obtained from multiple
dermatomes of the lower extremities. The present dataset will facilitate the clinical application of CHEPs
in the neurophysiological diagnosis of small fiber neuropathy and by discerning pathological findings help
establish a proximal-distal gradient of nerve degeneration in polyneuropathies.
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Normative data of contact heat 
evoked potentials from the lower 
extremities
J. Rosner1, P. Hostettler1, P. S. Scheuren1, L. Sirucek1, J. Rinert1, A. Curt1, J. L. K. Kramer2,3, 
C. R. Jutzeler1,2,3 & M. Hubli1
Contact heat evoked potentials (CHEPs) have become an acknowledged research tool in the assessment 
of the integrity of the nociceptive system and gained importance in the diagnostic work-up of patients 
with suspected small fiber neuropathy. For the latter, normative values for CHEP amplitude and latency 
are indispensable for a clinically meaningful interpretation of the results gathered in patients. To this 
end, CHEPs were recorded in 100 healthy subjects over a wide age range (20–80 years) and from three 
different dermatomes of the lower extremities (L2, L5, and S2). A normal baseline (35–52 °C) and 
increased baseline stimulation (42–52 °C) were applied. Statistical analysis revealed significant effects 
of stimulation site, stimulation intensity, and sex on CHEP parameters (N2 latency, N2P2 amplitude, 
and NRS). Significant positive correlations of body height with N2 latency, and pain ratings with 
N2P2 amplitudes were observed. This is the first time that normative values have been obtained from 
multiple dermatomes of the lower extremities. The present dataset will facilitate the clinical application 
of CHEPs in the neurophysiological diagnosis of small fiber neuropathy and by discerning pathological 
findings help establish a proximal-distal gradient of nerve degeneration in polyneuropathies.
Contact heat stimulation activates small diameter A-delta and C fiber nociceptors within the epidermis1,2. The 
recorded cortical potential is related to conduction within peripheral A-delta fibers, relayed to central spinotha-
lamic projections, thalamus and cortex3–5. Contact heat evoked potentials (CHEPs) have been employed to docu-
ment damage along the entire nociceptive neuraxis in a wide range of neurological diseases6–10.
The use of CHEPs in the neurophysiological assessment of disorders affecting the lower extremities has been 
challenged by a poor signal-to-noise ratio and technical drawbacks2,11,12. While several studies have reported 
normative values of CHEPs from the upper extremities11,13–15, few have addressed the lower extremity12.
The availability of such normative data may help close an important diagnostic gap in increasingly prevalent 
conditions, such as small fiber neuropathies16. Small fiber pathologies often pose a challenge as conventional 
neurophysiology does not yield conclusive results17,18.
The effect of stimulus intensity on the acquisition of CHEPs from the lower extremities has only recently been 
assessed systematically12. In that study, we demonstrated the superiority of the increased baseline (IB) protocol 
(42–52 °C) for the acquisition of CHEPs from lower extremities with higher signal persistence12. However, nor-
mative values for the lower extremities only exist for the normal baseline (NB) protocol (35–51 °C)11,13.
A recent multicenter study provides a large data set for commonly used stimulation sites11. However, the 
study protocol only included one site from the lower extremities, thus precluding its use for the assessment of 
length-dependency in polyneuropathies. As small fiber neuropathies often present in a distal-symmetrical fash-
ion owing to a length-dependency of fiber degeneration19, normative values from proximal and distal sites are 
needed in order to establish a neurophysiological gradient.
With the IB protocol being the preferable stimulation paradigm for CHEP acquisition from the lower extrem-
ities12, the need for a comprehensive set of normative values for both stimulation protocols is addressed here. 
Beyond the proof of feasibility, the present study provides normative values across a wide range of age groups. In 
particular, the inclusion of an older population is of high clinical relevance, as this cohort is epidemiologically 
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most often affected by polyneuropathies. As age already has a physiological impact on CHEP parameters, a robust 
and reliable stimulation paradigm (i.e., IB stimulation) is a requisite for a diagnostically meaningful approach.
Material and Methods
Subjects.  Hundred healthy subjects (47 men and 53 women) from three predefined age groups (20–40, 
41–60, and 61–80 years) were included. Inclusion criteria were native language either English or German. 
Exclusion criteria included pregnancy, intake of psychoactive medication, and any neurological condition.
All participants provided written informed consent prior to the assessments and all procedures described 
below were in accordance with the Declaration of Helsinki. The study has been approved by the local ethics 
board ‘Kantonale Ethikkommission Zürich, KEK’ (EK-04/2006, PB_2016-02051, clinicaltrial.gov number: 
NCT02138344).
Study design. Subjects medical history was assessed and subsequently nerve conduction as well as soma-
tosensory evoked potentials were recorded in order to exclude neuropathy. All subjects underwent a clinical 
sensory examination of mechanoreception and nociception, both of which were semi-quantitatively assessed 
according to the grading system of the International Standards for Neurological Classification of Spinal Cord 
Injury20. Afterwards subjects lay down in a supine position and three stimulation sites from the lower extremity 
were examined: the L2 dermatome at the inner side of the thigh, the L5 dermatome at the dorsum of the foot, 
and the S2 dermatome 5 cm above the popliteal fossa (Fig. 1C). The order of the tested dermatome and body side 
was randomized for each subject. CHEPs were recorded employing two different stimulation protocols: (1) the 
conventional normal baseline protocol (NB) followed by (2) the increased baseline protocol (IB). The two protocols 
differ by their applied baseline temperature, i.e., 35 °C for the normal and 42 °C for the IB protocol, while the peak 
temperature of 52 °C was the same for both protocols (Fig. 1D)21,22. A summary of the study protocol is illustrated 
in Fig. 1.
Acquisition of CHEPs. The CHEPs measurement set-up has been published elsewhere4,5,15,21,23. Briefly, the 
acquisition of CHEPs was performed using a contact heat stimulator with the established PATHWAY Pain & 
Sensory Evaluation System (Medoc Ltd., Ramat Yishai, Israel). The thermode surface of 27 mm consists of a heat-
ing thermo-foil covered with a layer of thermo-conductive plastic. The nominal heating rate of the thermode is 
70 °C/s (thermo-foil), with a cooling rate of 40 °C/s (peltier element).
Cortical potentials to the noxious heat stimuli were recorded with 9 mm Ag/AgCl cup electrodes filled with 
conductive adhesive gel. The recording sites on the scalp were prepared with Nuprep (D.O. Weaver & Co. Aurora, 
CO) and alcohol. Cup electrodes were positioned on the vertex (Cz) referenced to the earlobes (A1-A2) according 
to the 10–20 system (Fig. 1B). The vertex position is considered as the most reliable position to record N2 and P2 
potentials24. All signals were sampled at 2000 Hz using a preamplifier (20000x, bandpass filter 1–300 Hz, ALEA 
Solutions, Zurich, Switzerland). Data were recorded with 100 ms pre-trigger and a one second post-trigger in a 
customized program based on LabView (V2.04 CHEP, ALEA Solutions, Zurich, Switzerland).
Prior to the CHEP recordings, a familiarization procedure comprising a heat stimulus at the contralateral leg 
was applied. Contact heat stimuli were applied with an inter-stimulus interval of 8–12 sec. After each stimulus 
the thermode was marginally repositioned within the tested area to avoid peripheral receptor fatigue and habit-
uation1. In addition, cued by an auditory signal provided four seconds after heat stimulus, subjects were asked to 
rate the perceived intensity of each stimulus using a numeric rating scale (NRS) ranging from 0 (no pain) to 10 
(worst pain imaginable). The verbal instructions for the subjects comprised the following points: keep eyes open 
and fix a point on the ceiling, remain relaxed and quiet during the assessment, rate the perceived heat stimulus 
after the auditory signal on a scale ranging from 0 (no pain) to 10 (worst pain imaginable).
Data analysis and statistics. In both stimulation protocols, stimuli were applied with the goal of 15 
artifact-free signals without exceeding the total number of 20 trials. Signals were visually analyzed and trials with 
Figure 1. Summary of the study design: (A) clinical screening block including medical history, clinical sensory 
examination, somatosensory evoked potential (SEP), and nerve conduction study (NCS). (B) EEG setup for the 
CHEPs recording. (C) Stimulation sites of the CHEPs thermode. (D) Illustration of both stimulation protocols.
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obvious muscle or ocular artifacts were discarded. The remaining signals were averaged and the N2P2 amplitude 
was visually inspected by two independent examiners. The whole EEG analysis was performed using a custom-
ized program based on LabView (V2.04 CHEP, ALEA Solutions, Zurich, Switzerland).
R software (version 3.3.1) and SPSS software (version 16) for Windows was used to conduct all statistical 
analyses and generate the graphs. The data were tested for normal distribution using the Shapiro-Wilk test and 
by visually inspecting histograms and Q-Q plots. While N2 latencies and NRS were normally distributed, N2P2 
amplitudes were not. Statistical significance was set at α < 0.05 and was adjusted for multiple comparisons using 
Tukey contrasts.
To establish normative values, descriptive statistics (i.e., mean and 95% CI) were calculated. Sex difference in 
body height was tested using an independent t-test.
The main effects of stimulation protocol (i.e., NB, IB), stimulation sites (i.e., L2, L5, & S2), and age group were 
investigated by building a linear mixed model with protocol site and age group as fixed factors and random sub-
ject effects. Post-hoc tests were used to examine differences in CHEP parameters between stimulation sites under 
both stimulation paradigms.
Exploration of the effects of subject demographics such as age and body height as well as perceived pain dur-
ing testing on CHEP parameters was performed using pairwise Spearman correlations. An additional general 
linear mixed model was set up to test the effect of sex and height on CHEP parameters. N2 latency, N2P2 ampli-
tude, and NRS were set as dependent variables, while sex was included as a fixed factor and height as covariate. 
Examination of model diagnostics, in particular residuals of dependent variables, indicated that a logarithmic 
(log) transformation for amplitude data was necessary to meet model requirements for both general linear mixed 
models used.
Results
Subjects. A total of 100 healthy subjects participated in the study. Three had to be excluded due to the results 
of the clinical screenings, i.e., suspected neurological condition. The remaining subjects included 45 men and 
52 women with a mean age of 47.6 ± 17.2 years. The subjects had a mean height of 171.6 ± 8.7 cm and men were 
significantly taller than women (p < 0.001).
Main effects of stimulation protocol, stimulation site and age on CHEP parameters. The dataset 
of 97 included subjects was used to establish normative values for CHEPs for lower extremities. Figure 2 illus-
trates a representative example of averaged CHEP signals for all three tested sites and both stimulation protocols.
The normative values (mean ± 95% CI) of the investigated parameters (N2 latencies, N2P2 amplitudes, and 
pain ratings (NRS)) for each stimulation site, stimulation protocol and age group are summarized in Table 1. The 
middle-aged and the elderly subject group showed significantly longer latencies and smaller amplitudes com-
pared to the young group (see Table 2).
Figure 3 shows N2 latencies and N2P2 amplitudes for each tested site, stimulation protocol, grouped by age 
and sex. The linear mixed model revealed significant main effects of stimulation protocol, site and age (groups) 
on all investigated CHEP parameters. Sex had no significant effect on N2 latencies (F = 1.0, p = 0.3), and NRS 
(F = 1.2, p = 0.3) when corrected for height. However, log(N2P2 amplitudes) were significantly higher in females 
compared to males (F = 4.9, p = 0.029). Further post-hoc tests primarily displayed significant differences between 
the L5 dermatome and the two further proximally located stimulation sites (L2 & S2), while the L2 and S2 der-
matomes were comparable. Main effects and dermatome-wise comparisons are summarized in Table 2. In detail, 
the L5 dermatome featured longer N2 latencies and decreased N2P2 amplitudes.
Correlations of age, body height, and perceived pain. The Spearman correlation analysis of CHEP 
latencies and amplitudes with age, body height, and pain ratings consistently disclosed significant negative cor-
relations between age and N2P2 amplitudes (all p-values < 0.001). Significant positive correlations of age and N2 
latencies emerged in the L5 and the S2 dermatome in both protocols (p < 0.01 in L5 NB, L5 IB & S2 NB; p < 0.001 
in S2 IB). Body height was positively correlated with N2 latencies at all stimulation sites and for both stimulation 
protocols except S2 IB (p < 0.05 in L2 IB, L5 NB & L5 IB; p < 0.01 in L2 NB & S2 NB). In addition, pain ratings 
consistently correlated positively with amplitudes (p < 0.05 in L2 NB, L2 IB, L5 NB, L5 IB; p < 0.01 in S2 NB & S2 
IB). All correlation matrices are illustrated in Fig. 4.
Discussion
In the present study, we provide normative values for CHEPs from three stimulation sites on the lower extremi-
ties. These stimulation sites were chosen to allow for proximal-to-distal comparisons in length-dependent small 
fiber neuropathies. In addition, as each site reflects a specific spinal segment (dermatome), the normative values 
may also facilitate diagnoses in pathologies of the lumbar cord or in radiculopathies25,26.
In line with previous studies, age, and height had a significant influence on CHEP parameters11,27–29. The effect 
of age has been extensively debated by other authors27,30,31. Interestingly, in a study on laser evoked potentials, 
age had a significant influence on amplitudes but not latency27. The authors emphasized a central mechanism of 
amplitude attenuation, whereas the peripheral afferent input remains unaltered27. In contrast, a recent study from 
our group showed that latency was affected by age, yet only under the IB protocol15.
In the present study, age exerted a significant effect under both stimulation protocols. The discrepancy 
between the age-mediated effect on upper and lower extremities might be explained in terms of predominant 
vulnerability of fibers from the lower extremities during ageing, as most neuropathies manifest first in the lower 
extremities32. Subclinical dysfunctions may then contribute to increased latencies with ageing. Furthermore, con-
duction length from the lower extremities is generally longer possibly potentiating any jitter introduced by slight 
demyelination.
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Regarding length-dependency, stimulating the dorsum of the foot (L5 dermatome) yielded significantly longer 
N2 latencies and smaller N2P2 amplitudes than proximal (S2 or L2) stimulation. Moreover, stimulus intensity 
was perceived as less painful after distal stimulation. These results are readily explained by the longer peripheral 
conduction length, leading to temporal dispersion of the afferent volley2, and the proximal-to-distal gradient in 
skin innervation33. The fact that differences in latency between distal and proximal stimulation sites persist under 
both stimulation protocol is of clinical relevance. This possibly facilitates the detection of distally-accentuated 
impairments of axonal segments in length-dependent polyneuropathies.
In studies using laser- or contact heat stimulation, N2P2 amplitudes usually correlate well within subjects with 
ratings of pain intensity21. Higher NRS scores were associated with larger N2P2 amplitudes across all stimulation 
sites and under both stimulation paradigms. In line with the literature, females reported higher ratings to the 
Figure 2. Representative example of CHEPs recordings from the lower extremities (female, 51 years) using the 
normal and increased baseline protocol for each tested site (L2, S2 & L5). Averaged signals of the normal baseline 
protocol are displayed in black, while averaged signals of the increased baseline protocol are shown in blue.
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noxious heat stimuli34. Sex-related effects were also observed for N2 latencies and N2P2 amplitudes. As in pre-
vious studies15, we again draw upon longer conduction distances in the male subjects due to significantly greater 
height in order to explain these findings.
Applying the IB protocol led to shorter latencies and higher amplitudes for all stimulation sites and across 
all age groups15. The latency shift and amplitude increase were in a comparable range with data acquired for the 
upper extremities15. Stimulus characteristics should be taken into account when comparing results from different 
laboratories11,27. In slight contrast to previous studies applying CHEPs to the lower extremities11,13, pain ratings 
and some amplitudes (S2 and L2 dermatome) within the older population tend to be higher in the present study. 
These results can be explained in terms of improved temporal and spatial summation due to a more synchronized 
afferent volley using IB stimulation. A similar increase in amplitudes and subjective pain ratings was demon-
strated for the stimulation of cervical dermatomes15. In line with results from other groups, sex differences with 
females displaying larger N2P2 amplitudes could also be reproduced in our data set.
For CHEPs, bearing the inherent advantage of being able to control the baseline temperature, the IB protocol 
is well-established and the underlying mechanisms have been extensively studied15,21,22. Increasing the baseline 
temperature of stimulation shortens stimulus duration, decreases time to threshold for receptor activation and 
consequently leads to a more synchronized afferent volley with an improved spatio-temporal summation at 
central synapses22. Recently, we have demonstrated that using the IB protocol for the acquisition of CHEPs 
from the lower extremities can improve persistence of the cortical potential in a clinically meaningful man-
ner12. Our findings are in line with previous studies, Lagerburg et al. also reported improved acquisition when 
increasing the baseline temperature for stimulation in cases where there was no cortical response with NB 
stimulation13. Based on these observations, IB stimulation should be preferred over conventional stimulation 
whenever possible12.
Histological studies showed that both N2P2 amplitude and N2 latency correlate well with intra-epidermal 
nerve fiber density7,35,36. However, in the clinical routine N2 latency usually emerges as the more robust read-
out15,27,37, and has therefore been proposed as a more sensitive measure of pathology15,27 compared to amplitude. 
In line with literature15, amplitudes in the present study were also highly variable (i.e., high standard deviation) 
between subjects. Amplitudes are less reproducible over time for both upper and lower extremities12,37, and are 
susceptible to attention and arousal effects38,39.















N2 lat [ms] 33 400 [412] 33 296 [306] 31 415 [430] 31 306 [320] 24 406 [422] 30 304 [320]
N2P2 amp [µV] 33 33.7 [27.6, 39.8] 33 43.4 [36.7, 50.2] 31 19.8 [16.8, 22.8] 31 28.7 [24.5, 32.8] 24 20.6 [16.2, 25.1] 30 23.2 [17.8, 28.6]
NRS 34 5.2 [4.6, 5.8] 33 6.8 [6.2, 7.4] 33 5.3 [4.5, 6.0] 31 6.7 [5.9, 7.5] 30 5.8 [5.2, 6.4] 30 6.9 [6.3, 7.5]
L5
N2 lat [ms] 31 442 [456] 34 331 [345] 27 455 [475] 29 356 [373] 20 478 [500] 27 362 [381]
N2P2 amp [µV] 31 27.3 [23.0, 31.7] 34 34.13 [28.6, 39.5] 27 18.7 [15.9, 21.5] 29 26.9 [18.3, 35.4] 20 14.8 [11.9, 17.8] 27 19.9 [17.5, 22.3]
NRS 34 4.0 [3.4, 4.6] 34 5.8 [5.1, 6.5] 33 4.3 [3.5, 5.1] 32 5.7 [4.8, 6.6] 20 3.8 [3.1, 4.5] 30 5.8 [5.1, 6.5]
S2
N2 lat [ms] 33 408 [420] 33 291 [298] 31 426 [442] 31 324 [337] 23 428 [443] 22 315 [332]
N2P2 amp [µV] 33 34.4 [28.3, 40.5] 33 46.0 [39.1, 53.0] 31 22.8 [19.0, 26.6] 31 30.1 [25.5, 34.6] 23 25.0 [16.5, 33.5] 22 29.1 [23.0, 35.2]
NRS 33 5.4 [4.7, 6.1] 33 6.9 [6.3, 7.5] 32 6.0 [5.3, 6.8] 31 7.0 [6.3, 7.7] 29 6.4 [5.7, 7.1] 26 7.4 [6.7, 8.1]
Table 1. CHEPs parameters (N2 latency, N2P2 amplitude & pain rating (NRS)) for each stimulation site (L2, L5 
& S2) and for both protocols (normal baseline & increased baseline) displayed as mean ± 95% CI (only +95% 
CI for N2 latency) and the number of analyzed subjects (N) in each subgroup.
Main Effect Multiple Comparisons
Protocol Effect Dermatome Effect Age Group Effect
Comparison
Normal Baseline Increased Baseline
F p F p F p Estimate p Estimate p
N2 lat [ms] 1817.0 <0.001 141.3 <0.001 4.7 <0.05
L5 vs. L2 +51 <0.001 +47 <0.001
S2 vs. L2 +13 <0.01 +7 >0.05
S2 vs. L5 −38 <0.001 −40 <0.001
N2P2 amp 
[log(µV)] 121.1 <0.001 31.7 <0.001 19.0 <0.001
L5 vs. L2 −0.18 <0.01 − 0.17 <0.001
S2 vs. L2 +0.08 >0.05 +0.10 <0.05
S2 vs. L5 +0.26 <0.001 +0.27 <0.001
NRS 304.9 <0.001 138.3 <0.001 0.2 >0.05
L5 vs. L2 −1.4 <0.001 −1.1 <0.001
S2 vs. L2 +0.5 <0.01 +0.3 >0.05
S2 vs. L5 +1.8 <0.001 +1.4 <0.001
Table 2. Main effects of stimulation site, protocol and age group on CHEP parameters and multiple 
comparisons of stimulation sites.
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Currently, the diagnostic approach to a patient with suspected small fiber neuropathy usually includes bedside 
examination of sensory function for both mechano- and nociception19. Additional confirmatory tests, like quan-
titative sensory testing or skin biopsies are usually recommended to substantiate the clinical diagnosis19. CHEPs 
are so far not routinely used, however, would provide an objective readout of A-delta fiber function11. Here, we 
present normative values of CHEPs for the foot dorsum, a very distal and commonly affected area in small fiber 
neuropathies19, and two more proximal stimulation sites. Toe and foot involvement occur early during disease 
progression in many peripheral neuropathies32. The relative sparing of proximal sites may facilitate the monitor-
ing of symptom progression over time in a distal-to-proximal fashion.
CHEPs do not only bear potentially high diagnostic yield in length-dependent polyneuropathies, but also in 
patients with non-length dependent patterns of sensory abnormalities. For the latter, CHEPs can be employed as 
a sensitive measure of spinal pathology, i.e. myelopathy5,9. Such concomitant spinal pathology cannot be detected 
by skin biopsies, nor be adequately localized using quantitative sensory testing18. Hence, CHEPs may supplement 
the neurophysiological test battery as a non-invasive, objective and clinically applicable technique.
Limitations
A major limitation of this study is the collection of normative data at only one center. Therefore, the use of the 
acquired normative values for CHEPs in lower extremities is limited to clinical sites using the exact same CHEP 
acquisition equipment. This makes the generalizability of the data weaker compared to multicenter normative 
data sets.
Conclusion
In this study we provide normative values for the acquisition of CHEPs from lower extremities in a large cohort of 
healthy subjects across different age groups. Age, height and sex have substantial impact on the latency and ampli-
tude of CHEPs. Latencies exhibit length-dependency allowing for an appropriate diagnosis of a proximal-distal 
gradient in peripheral neuropathies.
Figure 3. N2 latencies and N2P2 amplitudes for each stimulation site (L2, L5 & S2), both stimulation protocols 
(normal baseline (NB) & increased baseline (IB)), both sexes and three age groups. The subjects are color coded 
according to their age group.
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Increasing stimulation intensity markedly shortens latencies and increases amplitudes through reduced signal 
dispersion along the afferent fibers. This comprehensive set of normative values will improve the neurophysi-
ological diagnosis of patients with small fiber neuropathies or neuropathic pain conditions affecting the lower 
extremities.
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